Abstract
HIV infection has been associated with alterations in gut microbiota and related microbial metabolite production. However, the mechanisms of how these functional microbial metabolites may affect HIV immunopathogenesis and comorbidities, such as cardiovascular disease and other metabolic diseases, remain largely unknown. Here we review the current understanding of gut microbiota and related metabolites in the context of HIV infection. We focus on several bacteria-produced metabolites, including tryptophan catabolites, short-chain fatty acids and trimethylamine-N-oxide (TMAO), and discuss their implications in HIV infection and comorbidities. We also prospect future studies using integrative multiomics approaches to better understand host-microbiota-metabolites interactions in HIV infection, and facilitate integrative medicine utilizing the microbiota in HIV infection.
Original language | English (US) |
---|---|
Pages (from-to) | 335-347 |
Number of pages | 13 |
Journal | Future Virology |
Volume | 14 |
Issue number | 5 |
DOIs | |
State | Published - 2019 |
Keywords
- HIV
- integrative omics
- metabolites
- metabolomics
- microbiota
ASJC Scopus subject areas
- Virology